Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04329325
Title Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center

acute lymphoblastic leukemia


Dasatinib + Dexamethasone + Methotrexate

Blinatumomab + Dasatinib + Methotrexate

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Hospital Recruiting New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from for the field